Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

v3.23.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jul. 02, 2023
Jul. 03, 2022
Jul. 02, 2023
Jul. 03, 2022
Income Statement [Abstract]        
Revenue $ 42 $ 5,101 $ 63 $ 5,101
Cost of revenue 14,235 5,739 26,483 6,254
Gross margin (14,193) (638) (26,420) (1,153)
Operating expenses:        
Research and development 16,553 15,827 40,302 28,558
Selling, general and administrative 16,688 11,566 43,962 23,435
Impairment of equipment 4,411 0 4,411 0
Total operating expenses 37,652 27,393 88,675 51,993
Loss from operations (51,845) (28,031) (115,095) (53,146)
Other income (expense):        
Change in fair value of common stock warrants (14,340) 26,400 (27,180) 94,200
Interest income 3,150 629 5,616 653
Interest expense (1,270) 0 (1,270) 0
Other income (expense), net (1) (133) 20 (135)
Total other income (expense), net (12,461) 26,896 (22,814) 94,718
Net income (loss) $ (64,306) $ (1,135) $ (137,909) $ 41,572
Net income (loss) per share, basic (in dollars per share) $ (0.41) $ (0.01) $ (0.88) $ 0.27
Weighted average number of common shares outstanding, basic (in shares) 157,151,386 152,521,389 156,397,145 152,082,655
Net loss per share, diluted (in dollars per share) $ (0.41) $ (0.18) $ (0.88) $ (0.34)
Weighted average number of common shares outstanding, diluted (in shares) 157,151,386 152,521,389 156,397,145 152,924,803